NeurAxis, Inc. (NASDAQ:NRXS – Get Free Report) fell 4.1% during trading on Tuesday . The stock traded as low as $2.50 and last traded at $2.59. 40,873 shares were traded during trading, an increase of 67% from the average session volume of 24,518 shares. The stock had previously closed at $2.70.
NeurAxis Trading Down 4.1 %
The stock has a 50-day moving average of $2.71 and a two-hundred day moving average of $2.89. The firm has a market cap of $18.08 million, a price-to-earnings ratio of -1.41 and a beta of 4.20.
About NeurAxis
NeurAxis, Inc, a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome.
Read More
- Five stocks we like better than NeurAxis
- Canada Bond Market Holiday: How to Invest and Trade
- Disney: Forging a 3-Headed Sports Streaming Giant With Fubo Deal
- How to Invest in Blue Chip Stocks
- How Buffett’s Best and Worst Stock Bets Have Fared 5 Years Later
- 3 REITs to Buy and Hold for the Long Term
- Bill Ackman’s Bold Case for Fannie Mae and Freddie Mac
Receive News & Ratings for NeurAxis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeurAxis and related companies with MarketBeat.com's FREE daily email newsletter.
